Table 8.
Median Overall Survival of Patients With Stages I to IIIA NSCLC According to Treatment and UICC Stagea.
| N | Events | Median (months) | CI (months) | |
|---|---|---|---|---|
| Standard_uicc I | 31 | 6 | NA | 8.93-NA |
| Standard + VA_uicc I | 4 | 0 | NA | NA-NA |
| Standard_uicc II | 27 | 8 | 21.3 | 12.87-NA |
| Standard + VA_uicc II | 7 | 3 | 33.2 | 12.03-NA |
| Standard_uicc IIIA | 35 | 10 | 24.8 | 13.20-NA |
| Standard+VA_UICC IIIA | 6 | 4 | 15.1 | 14.43-NA |
| Log rank test Χ²= 2.2 on 5 degrees of freedom, p= 0.8 | ||||
Abbreviations: NSCLC, non–small cell lung carcinoma; UICC, Union for International Cancer Control; CI, confidence interval; NA, not available; VA, Viscum album L.
a
Median overall survival in accordance to treatment and UICC stage, n = 110. Standard, oncological standard treatment; Standard + VA, oncological standard treatment plus add-on VA.